Log In
BCIQ
Print this Print this
 

Humaclot

  Manage Alerts
Collapse Summary General Information
Company Kedrion Group S.p.A.
DescriptionHuman plasma coagulation Factor VII
Molecular Target
Mechanism of Action 
Therapeutic Modality 
Latest Stage of DevelopmentMarketed
Standard IndicationBleeding
Indication DetailsTreat von Willebrand disease
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today